Sarcomatoid-variant renal cell carcinoma: Treatment outcome and survival in advanced disease Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Carcinoma, Papillary
  • Carcinoma, Renal Cell
  • Kidney Neoplasms

abstract

  • Metastatic sarcomatoid-variant RCC was associated with a poor response to systemic therapy. Sunitinib treatment resulted in a modest response rate, but studies to characterize the underlying tumor biology of sarcomatoid-variant RCC, to assess outcome to targeted agents, and to develop novel treatment strategies are warranted.

publication date

  • October 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3661202

Digital Object Identifier (DOI)

  • 10.1097/COC.0b013e3181f47aa4

PubMed ID

  • 21127411

Additional Document Info

start page

  • 454

end page

  • 9

volume

  • 34

number

  • 5